Business
RENNOVA HEALTH POSTPONES SPECIAL MEETING OF STOCKHOLDERS TO MAY 2, 2018
RENNOVA HEALTH POSTPONES SPECIAL MEETING OF STOCKHOLDERS TO MAY 2, 2018.
About this update from Rennova Health, Inc.
[{"type":"text","content":"\n\n WEST PALM BEACH, Fla, April 25, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, announces the postponement of its Special Meeting of Stockholders to May 2, 2018 at 11:00 a.m. Eastern time at the offices of Shutts & Bowen LLP, 525 Okeechobee Boulevard, Suite 1100, West Palm Beach, FL 33401. The record date of March 12, 2018 remains unchanged. This Special Meeting was originally scheduled for April 18, 2018.\n “Stockholder approval of the proposed increase in authorized common shares plus the ability to enact a reverse stock split is critical for the company going forward,” stated Seamus Lagan, President and Chief Executive Officer of Rennova adding “Should any of the company’s convertible debt or preferred stock holders elect to exercise or convert their shares, the company currently does not have sufficient shares to meet those obligations.” “The agreements under which many of the convertible debt and preferred stock securities were issued require the company to seek an increase in the number of authorized shares of common stock to accommodate all of the possible issuances,” noted Mr. Lagan. If you have already voted and wish to change your vote or if you are ready to vote your shares now, please call our proxy solicitor, Advantage Proxy toll free at 1-877-870-8565 for assistance. The Special Meeting is for the following purposes: 1. To approve an amendment to our certificate of incorporation, as amended, to effect a reverse stock split of all of the outstanding shares of our common stock, par value $0.01 per share, at a specific ratio within a range of 1-for-50 to 1-for-300, and to grant authorization to our Board of Directors to determine, in its discretion, the specific ratio and timing of the reverse stock split any time before March 1, 2019, subject to the Board of Directors’ discretion to abandon such amendment; 2. To approve an amendment to our certificate of incorporation, as amended, to increase the number of authorized shares of our common stock from 500,000,000 to 3,000,000,000 shares;  ...